Smallpox abstract: 2006 report on in vitro evaluation of the antiviral compound ST-246

The WHO Collaborating Center for smallpox and other poxviruses at the Centers for Disease Control and Prevention Atlanta, GA

17 November 2006

| Publication

As recommended by the U.S. government, antiviral compounds are under current

investigation as therapeutic options for the treatment of smallpox in the event of an

intentional or accidental release of variola virus. ST-246 is a compound that specifically

targets a viral assembly protein which is required for extracellular virus formation.

WHO Team

Communicable Diseases

Number of pages